SCM
XENE icon

Sio Capital Management’s Xenon Pharmaceuticals XENE Stock Holding History

Sio Capital Management’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-16,368
Closed -$498K – 61
2022
Q2 		$498K Sell
16,368
-89,388
-85% -$2.7M 0.19% 51
2022
Q1 		$3.23M Buy
+105,756
New +$3.17M 1.07% 24

Other funds holding XENE

ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Sio Capital Management's XENE Position: Q3 2022 in Review

Sio Capital Management sold out of Xenon Pharmaceuticals (XENE) in Q3 2022, closing a stake of 16,368 shares — an estimated $498K sold.

Sio Capital Management first reported a position in XENE in Q1 2022 and held it in 2 quarters. The position peaked at $3.23M in Q1 2022. 154 funds tracked by Wall St. Rank hold XENE as of Q3 2022.

  • Sio Capital Management reported no remaining Xenon Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Sio Capital Management sold 16,368 Xenon Pharmaceuticals shares in Q3 2022, an estimated $498K.
  • Sio Capital Management first reported a position in Xenon Pharmaceuticals in Q1 2022 and held it in 2 quarters.
  • Sio Capital Management's Xenon Pharmaceuticals position peaked at $3.23M in Q1 2022.
  • 154 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q3 2022.

Based on Sio Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.